The Multiple Sclerosis (MS) therapeutic scenario has radically changed in the last few years, due to new insights on disease pathogenesis and course. Although MS is considered a prototype of the central nervous system (CNS) diseases, the therapeutic possibilities are based primarily on ...
Researchers also found that the therapy even prevented MS from developing in the majority of mice they treated with it. "This is the first time anyone has shown how the fusion of this protein to immunosuppressive cytokines can treat and prevent multiple sclerosis," said Jun Ishihara, a former ...
How much do multiple sclerosis treatments cost? Treating multiple sclerosis costs a great deal for patients and communities. Individually, the nearly 1 million people with MS pay an average annual cost of more than $88,000 for the various treatment options, devices, daily living needs, and insur...
Mitoxantrone (Novantrone) is achemotherapyagent that has been approved by the FDA to treat multiple sclerosis. Treatment with mitoxantrone requires monitoring of cardiac function, and there is a fixed limit to the dose that can be administered to patients. It also carries the long-term risk ofl...
Multiple sclerosis (MS) is a leading cause of chronic neurological disability in young to middle-aged adults, affecting ~2.5 million people worldwide. Currently, most therapeutics for MS are systemic immunosuppressive or immunomodulatory drugs, but these
Patients with multiple sclerosis (MS) require long-term therapy and have a wide variety of needs for health-related support. The efficacy and safety of MS therapy, as assessed by both clinicians and patients, are important parameters that need to be considered. However, few studies combine data...
MS TREATMENT The management of MS involves decreasing signs of disease progression, in addition to treating the day to day symptoms that affect a person’s quality of life. Successful Multiple Sclerosis therapy involves traveling down both of these paths and receiving guidance to do so. The menu...
5) multiple primary/therapy 多发原发性/治疗6) multiple sclerosis 多发性硬化 1. Effect of glucocorticoid on expression of CD40 and CD40 ligand of peripheral blood lymphocyte in patients with multiple sclerosis; 糖皮质激素对多发性硬化患者外周血淋巴细胞CD40和CD40L表达的影响 2. Texture analysis on...
Francesco PattiDepartment of Neurology, University of Catania, Catania, ItalyAbstract: Poor treatment adherence is problematic in many therapy areas, including multiple sclerosis (MS). Several immunomodulatory drugs are available for the treatment of MS, all of which require frequent parenteral administrati...
Multiple SclerosisImmunotherapyCurrently there are no therapies able to heal Multiple Sclerosis (MS). However, depending on the stage and course of the disease, there are treatments available that can efficiently treat relapses, redoi:10.1007/978-88-470-2676-6_9Prof. Alessandro d’Ambrosio...